APA

Hall W. A., Petrova A. V., Colbert L. E., Hardy C. W., Fisher S. B., Saka B., Shelton J. W., Warren M. D., Pantazides B. G., Gandhi K., Kowalski J., Kooby D. A., El-Rayes B. F., Staley C. A., Volkan Adsay N., Curran W. J., Landry J. C., Maithel S. K. & Yu D. S. (20150428). Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. : Oncogene.

Chicago

Hall W A, Petrova A V, Colbert L E, Hardy C W, Fisher S B, Saka B, Shelton J W, Warren M D, Pantazides B G, Gandhi K, Kowalski J, Kooby D A, El-Rayes B F, Staley C A, Volkan Adsay N, Curran W J, Landry J C, Maithel S K and Yu D S. 20150428. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. : Oncogene.

Harvard

Hall W. A., Petrova A. V., Colbert L. E., Hardy C. W., Fisher S. B., Saka B., Shelton J. W., Warren M. D., Pantazides B. G., Gandhi K., Kowalski J., Kooby D. A., El-Rayes B. F., Staley C. A., Volkan Adsay N., Curran W. J., Landry J. C., Maithel S. K. and Yu D. S. (20150428). Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. : Oncogene.

MLA

Hall W A, Petrova A V, Colbert L E, Hardy C W, Fisher S B, Saka B, Shelton J W, Warren M D, Pantazides B G, Gandhi K, Kowalski J, Kooby D A, El-Rayes B F, Staley C A, Volkan Adsay N, Curran W J, Landry J C, Maithel S K and Yu D S. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. : Oncogene. 20150428.